ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 285116 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 285116; 2) Community: the network communities that were significantly associated with the response to NSC 285116; 3) Molecule: the relationships between components within communities and NSC 285116; 4) MDR: the compounds that were significantly associated with the NSC 285116.

NSC Compound Enrichment Correlation
NSC 693636 Null 0.024108502230778 0.20649922
NSC 696990 Null 0.024108502230778 0.40072425
NSC 713608 Null 0.024108502230778 0.3689025
NSC 740259 Null 0.024108502230778 0.25107451
NSC 740276 5,6-Dihydro-6-[3-(hydroxyethyl)amino-1-propyl]-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloide 0.024108502230778 0.43519156
NSC 12198 Dromostanolone Propionate 0.0241085022307781 0.43859647
NSC 128571 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) 0.0241085022307781 0.48478741
NSC 205555 Butanoic acid, 2,3-dibromo-4-[(5-chloro-2-methoxyphenyl)amino]-4-oxo- 0.0241085022307781 0.4516857
NSC 105014 Cladribine 0.0247979034812109 0.17248272
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0247979034812109 0.1754646
Total:104  Current:59    [First] [Prev] [Next] [Last]